Search results for: 'research area tyrosine kinase insulin receptor'
-
BA6333 BI-4020Summary: BI-4020 is a fourth generation, orally active, non-covalent tyrosine kinase inhibitor. - BA8784 IruplinalkibSummary: Iruplinalkib (WX-0593) is a potent, selective, orally active and tyrosine kinase inhibitor.
- BA8804 VodobatinibSummary: Vodobatinib (K0706) is a potent third-generation, and orally active, tyrosine kinase inhibitor.
- BA8806 VamotinibSummary: Vamotinib (PF-114) is a potent, selective tyrosine kinase inhibitor with oral activity.
- BA8886 BPI-9016MSummary: BPI-9016M is a potent, orally active, selective dual and tyrosine kinase inhibitor.
- BA8956 CEP-11981Summary: CEP-11981 (ESK981; BOL303213X) is an orally active tyrosine kinase inhibitor (TKI).
-
A8464 LY21097614 CitationSummary: TβRI/II kinase inhibitor -
A8812 PD173955Target: Bcr-Abl|SrcSummary: Dual Src/Abl kinase inhibitor, ATP-competitive, -
A4152 BMS-911543Target: JAKSummary: JAK2 inhibitor,selective small molecule -
A4151 ZM 39923 HClTarget: JAKSummary: JAK3 inhibitor,potent and selective